For years oncho and lymphatic filariasis have ravaged individuals, families, and communities. And for years we have been fighting to beat them. Thanks to
Summer and autumn have seen the careful resumption of Mectizan® mass drug administration (MDA) campaigns around the world with COVID-19 safety measures in place.
Lymphatic filariasis: managing morbidity and preventing disability: an aide-mémoire for national program managers, 2nd ed. World Health Organization, 2021 Overview: Since the first edition
Safety in administering medicines for neglected tropical diseases. World Health Organization, 2021 Overview: The objective of this manual is to provide practical tools, including
Determination, innovation and adaptation can keep lymphatic filariasis elimination on track October 21, 2021 World Health Organization COVID-19 has severely disrupted the implementation of
Progress in eliminating onchocerciasis in the WHO Region of the Americas: disruption of ivermectin mass drug administration in the Yanomami focus area due to
Authors: Emily Toubali, Molly Brady, Ernest Mensah, Aryc Mosher, Emily Wainwright, Liz Eddy, Aria Gray, and Alyssa Jordan Multi-country experiences in implementing a direct
Authors: Elizabeth Fitch, Alison Krentel, Kevin Bardosh, Beth Sutherland, Alyssa Jordan, and Margaret Baker The World Health Organization’s 2021-2030 NTD Road Map advocates for
Part of the Act to End NTDS | East technical brief series June 2021. To eliminate human onchocerciasis transmission of the filarial parasite Onchocerca
Onchocerciasis: diagnostic target product profile to support preventive chemotherapy. WHO, 2021. Overview Onchocerciasis, also known as river blindness, affects an estimated 21 million people,
Video recordings from “The Power of Partnership: Defeating Onchocerciasis” symposium are ready to view. Featuring 29 speakers from diverse aspects of the campaign, the
